23.01.2013 Views

IJUP08 - Universidade do Porto

IJUP08 - Universidade do Porto

IJUP08 - Universidade do Porto

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Prenylated and bromoalkylated xanthones as potential antitumor<br />

agents: synthesis and biological activities<br />

A. Paiva 1,3 , E. Sousa 1,3 , M. Pinto 1,3 , A. Camões 2,3 , N. Nazareth 2,3 and M. S. J.<br />

Nascimento 2,3<br />

1 Department of Organic Chemistry, Faculty of Pharmacy, University of <strong>Porto</strong>, Portugal.<br />

2 Department of Microbiology, Faculty of Pharmacy, University of <strong>Porto</strong>, Portugal.<br />

3 Research Centre of Organic Chemistry, Phytochemistry and Pharmacology of the University of<br />

<strong>Porto</strong> (CEQOFFUP), Faculty of Pharmacy, University of <strong>Porto</strong>, Portugal.<br />

In order to improve the growth inhibitory effect of 3,4-dihydroxyxanthone (1) on human<br />

tumor cell lines [1], the synthesis of new prenylated and bromoalkylated derivatives was<br />

planned. Three prenylxanthones (2-4), as well as two bromohexyloxyxanthones, (5, 6)<br />

were obtained by different synthetic pathways (Fig. 1). The structures of compounds 2-6<br />

were established by spectroscopic methods (IR, NMR of 1 H and 13 C, HMBC and HSQC)<br />

and mass spectrometry.<br />

O<br />

O<br />

1<br />

OH<br />

BrCH 2 CHC(CH 3 ) 2<br />

K 2CO 3 ,DMF,reflux<br />

OH<br />

Br CH 2 CHC(CH 3 ) 2<br />

K 2 CO 3 ,DMF,r.t.<br />

Br(CH 2) 6Br<br />

(drop-to-drop)<br />

K 2 CO 3 ,DMF,r.t.<br />

O<br />

O<br />

O<br />

2<br />

OH<br />

O<br />

+<br />

O O<br />

O<br />

3<br />

O<br />

4<br />

Fig. (1). Synthesis of prenylated and bromoalkylated xanthones.<br />

5<br />

O<br />

O<br />

O<br />

O<br />

The effects of xanthones 2-6 on the in vitro growth of estrogen receptor positive (ER +)<br />

MCF-7 and estrogen receptor negative (ER −) MDA-MB-231 cells were investigated.<br />

Prenylated compounds 2-4 and monobromoalkylxanthone 6 were more potent than the<br />

parent compound 1. Moreover, compounds 2-4 revealed selectivity against ER(+) MCF-7<br />

cells. Compound 2, the most potent derivative (GI50 = 5 µM, MCF-7), showed an<br />

antiproliferative effect either on complete and steroid-free RPMI medium suggesting not to<br />

be dependent on estrogenic stimulation. The growth inhibitory action of the antiestrogen 4hydroxytamoxifen<br />

in ER(+) MCF-7 cell line was strongly enhanced by compound 2. This<br />

is the first report of interactions between xanthones and an antiestrogen.<br />

References:<br />

[1] Pedro M., Cerqueira, F., Sousa, M.E., Nacimento, M.S.J. and Pinto, M. (2002), Xanthones as<br />

inhibitors of growth of human cancer cell lines and their effects on the proliferation of human<br />

lymphocytes in vitro, Bioorganic Medicinal Chemistry, 10 (12), 3725-3730.<br />

Acknowledgments: FCT (I&D, nº226/94), FEDER, POCI for financial support.<br />

Br<br />

O<br />

Br<br />

OH<br />

+<br />

O<br />

O<br />

O<br />

6<br />

OH<br />

O<br />

Br<br />

66

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!